Catlin Group Limited
19 March 2008
Catlin Group Limited
19 March 2008
CATLIN GROUP LIMITED (the 'Company')
Dealings by the Trustees of the Catlin Group Employee Benefit Trust (the 'EBT')
The Company received notification yesterday that the Trustees of the EBT have
acquired common shares of $0.01 each in the capital of the Company ('Shares') as
detailed below:
Number of Shares Average price paid Date of purchase
purchased per Share
1,162,976 £4.27 14 March 2008
482,615 £4.03 17 March 2008
The EBT is a trust for the benefit of employees of the Company and its
subsidiaries ('Group').
The executive directors of the Company, Stephen Catlin and Christopher Stooke,
together with Richard Banas, Paul Brand, Paul Jardine and Preben Prebensen
(being persons discharging managerial responsibilities) have an interest in the
Common Shares acquired as potential beneficiaries under the EBT in respect of
their participation in Group share schemes.
The purchase of the Shares took place over the London Stock Exchange.
This notification is made in accordance with Rule 3.1.4R (1) (a) of the
Disclosure and Transparency Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.